This $750,000 Project Grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will support the Chapa-De Indian Health Program, Inc. in enhancing its comprehensive healthcare services for American Indian, Alaska Native (AIAN), and other underserved patients in California. The funding will enable Chapa-De to expand and improve its...
This $341,268 Project Grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will support the Karuk Tribe's efforts to address the opioid overdose crisis in its tribal communities. The funding will be used to increase access to FDA-approved medications for opioid use disorder (OUD) treatment, provide a sober transitional recovery home for...
This federal Project Grant award of $750,000 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The award will support the Shingle Springs Band of Miwok Indians, a federally recognized tribe located in El Dorado County, California, to implement a comprehensive Opioid Response project. The key products and services to be delivered through...
The Department of Health and Human Services' Indian Health Service awarded a $500,000 Project Grant (CFDA 93.933 - Demonstration Projects for Indian Health) to Native Directions, Inc. on February 1, 2025. The grant aims to expand opioid use disorder (OUD) prevention, treatment, and recovery services for Native American/Alaska Native (NA/AN) communities in San Joaquin, Stanislaus, and Tuolumne counties in California. Key objectives include: Increasing NA/AN community awareness and education about...
The Riverside-San Bernardino County Indian Health, Inc. (RSBCIHI) was awarded a $500,000 Project Grant under the Demonstration Projects for Indian Health (CFDA 93.933) program administered by the U.S. Department of Health and Human Services' Indian Health Service. The purpose of this 5-year grant (2/1/2025 - 1/31/2030) is to: 1) increase access to Medications for Opioid Use Disorder (MOUD) for individuals with Opioid Use Disorder (OUD); and 2) decrease illicit opioid use and prescription...
The Department of Health and Human Services' Indian Health Service awarded a $500,000 Project Grant under the Demonstration Projects for Indian Health (CFDA 93.933) program to the Sacramento Native American Health Center (SNAHC) on February 1, 2025. The grant will fund the SNAHC Community Opioid Intervention Prevention Program, which aims to: (1) reduce unmet treatment needs and opioid overdose-related deaths through Medicated Assisted Treatment (MAT); (2) reinforce comprehensive support teams...
The Department of Health and Human Services' Indian Health Service has awarded a $500,000 Project Grant under the Demonstration Projects for Indian Health (CFDA 93.933) program to the Toiyabe Indian Health Project, Inc. The grant will fund a 5-year project from February 1, 2025 to January 31, 2030 to address the opioid crisis impacting tribal communities in rural Inyo and Mono Counties, California. The Toiyabe Indian Health Project, a tribally-owned nonprofit organization, will use the funding...
The Tuolumne Me-Wuk Indian Health Center, Inc. was awarded a $458,072 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program from the Substance Abuse and Mental Health Services Administration (SAMHSA). The grant will fund a 5-year project to provide culturally responsive medically assisted treatment (MAT), harm reduction, and wellness programming to address the opioid crisis affecting American Indians, Alaska...
The Department of Health and Human Services' Indian Health Service awarded a $1,000,000 Project Grant under the Demonstration Projects for Indian Health (CFDA 93.933) program to Nevada Urban Indians, Inc. to establish an Opioid Response Program. The program will serve the Reno, Sparks, Carson City and surrounding areas of Northern Nevada, which has seen a 49% increase in opioid-related emergency room overdose visits in the past year. The key objectives of the Opioid Response Program are to: 1)...
The Wichita And Affiliated Tribes will implement the "Being Every Addict's Reason 2 (BEAR 2)" program, a $795,634 comprehensive opioid and stimulant use prevention project funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The 5-year project aims to reduce overdose deaths among Native Americans in the IHS Lawton Service Area of...
CHAPA-DE INDIAN HEALTH (CHAPA-DE) TREATMENT, RECOVERY & HARM REDUCTION - CHAPA-DE INDIAN HEALTH WILL ADDRESS OPIOID USE DISORDERS (OUD) AND SUBSTANCE USE DISORDERS (SUD) BY PROVIDING COMPREHENSIVE, FLEXIBLE, CULTURALLY ATTUNED TREATMENT, RECOVERY, AND HARM REDUCTION SERVICES THAT INCORPORATE NATIVE HEALING PRACTICES, TO AMERICAN INDIANS AND ALASKA NATIVES (AIAN) AND LOW INCOME INDIVIDUALS IN CALIFORNIA'S PLACER AND NEVADA COUNTIES AND SURROUNDING AREAS. WE WILL SERVE 162 UNDUPLICATED INDIVIDUALS WITH A 50% RETENTION RATE. NEED & POPULATION TO BE SERVED: CHAPA-DE'S PROGRAM WILL ADDRESS THE SIGNIFICANT INCREASE IN OPIOID DEATH RATES, PARTICULARLY FOR THE AIAN POPULATION AND OTHER BIPOC INDIVIDUALS, THE RISING USE OF STIMULANTS, AND THE LOW PERCENTAGE OF PEOPLE THAT SEEK CARE. THE PROGRAM WILL INCREASE ACCESS TO CULTURALLY ATTUNED AND COMPREHENSIVE MEDICATION ASSISTED TREATMENT (MAT) FOR OUDS (MOUD) AND OTHER SUD TREATMENT IN OUR UNDERSERVED COMMUNITY. CHAPA-DE WILL SERVE AIAN AND OTHER LOW-INCOME ADULTS, INCLUDING PRENATAL AND POSTPARTUM PATIENTS, AND UNHOUSED PATIENTS, IN THE CHAPA-DE SERVICE AREA WHICH INCLUDES CALIFORNIA'S PLACER AND NEVADA COUNTIES AND SURROUNDING AREAS. CHAPA-DE IN PRIVILEGED TO PARTNER WITH AND OPERATE UNDER THE AUTHORITY OF THE UNITED AUBURN INDIAN COMMUNITY TO PROVIDE FREE AND CULTURALLY RELEVANT CARE TO AIAN PEOPLE FROM FEDERALLY RECOGNIZED AND CALIFORNIA TRIBES. OF CHAPA-DE'S 2021 PATIENT BASE OF 25,132, 30% WERE AIAN. STRATEGIES/INTERVENTIONS: CHAPA-DE WILL EMPLOY SEVERAL EVIDENCE BASED PRACTICES FOR TREATING OUD AND OTHER SUDS INCLUDING NURSE CASE MANAGEMENT MODEL FOR MOUD; PERINATAL CARE WITH MAT; NATIVE RECOVERY PROGRAMS INCLUDING RED ROAD TALKING CIRCLES; BEHAVIORAL HEALTH SUPPORT INCLUDING COGNITIVE BEHAVIORAL THERAPY (CBT); CONTINGENCY MANAGEMENT FOR STIMULANT USE; SEEKING SAFETY; AND SUD SCREENING AND SBIRT INTERVENTIONS. OUR PROGRAM IS BECOMING A BEACON IN THE COMMUNITY AND INCREASING SPECIALIZED STAFFING; RESUMING FORMAL CONTINGENCY MANAGEMENT FOR STIMULANT USE; AND INCREASING HARM REDUCTION, OUTREACH AND AWARENESS-RAISING ACTIVITIES, WILL ENHANCE OUR OFFERINGS. GOAL 1: EFFECTIVELY SERVE AIAN AND OTHER CHAPA-DE PATIENTS WITH COMPREHENSIVE NURSE CASE MANAGED MOUD/SUD TREATMENT AND RECOVERY SERVICES SUPPLEMENTED BY BEHAVIORAL HEALTH CARE/THERAPY, AND NATIVE HEALING PRACTICES. GRANT FUNDING WILL SUPPORT HIRING AN ADDITIONAL SUD NURSE CASE MANAGER, AN SUD COUNSELOR, TWO PART-TIME SUD THERAPISTS AND ADDITIONAL ADMINISTRATIVE AND CLINIC STAFF TO INCREASE CAPACITY TO SERVE MORE PATIENTS WITH COMPREHENSIVE SERVICES. KEY EXPECTED OUTCOMES AND OBJECTIVES INCLUDE (I) SERVING A TOTAL OF 162 PATIENTS DURING THE GRANT PERIOD; AND (II) MAINTAINING A PROGRAM RETENTION RATE OF AT LEAST 50%. GOAL 2: ENHANCE MOUD/SUD TREATMENT SERVICES. KEY OBJECTIVES INCLUDE THE (I) IMPLEMENTATION OF A COMPREHENSIVE CONTINGENCY MANAGEMENT PROGRAM THAT ANNUALLY SERVES 20 PATIENTS BEING TREATED FOR STIMULANT USE, AND (II) THE DEVELOPMENT OF FIDELITY MONITORING PROTOCOLS FOR NURSE CASE MANAGEMENT MODEL FOR MOUD, PERINATAL CARE WITH MAT, BEHAVIORAL HEALTH SUPPORT INCLUDING CBT, CONTINGENCY MANAGEMENT, AND SBIRT. GOAL 3: IMPLEMENT HARM REDUCTION EFFORTS THAT INCLUDE EQUIPPING PATIENTS AND COMMUNITY MEMBERS WITH REVERSAL MEDICATIONS AND FENTANYL TEST STRIPS (FTS) AND INCREASING COMMUNITY AWARENESS OF TREATMENT AND RECOVERY OPTIONS. KEY OBJECTIVES INCLUDE: (I) PURCHASING AND DISTRIBUTING A SUPPLY OF 50 NALOXONE/NARCAN DOSES AND 2,120 FTS; (II) PROVIDING A LEAST TWO (2) TRAININGS PER YEAR FOR PATIENTS, PEERS, FAMILY MEMBERS, AND OTHER KEY TRIBAL MEMBERS ON THE RECOGNITION OF OPIOID OVERDOSE AND APPROPRIATE USE OF THE OVERDOSE REVERSAL/PREVENTION MEDICATIONS; AND (III) IMPLEMENTING AN OUTREACH AND AWARENESS RAISING CAMPAIGN TO ENSURE THE WIDER COMMUNITY IS AWARE OF THE CHAPA-DE TREATMENT, RECOVERY & HARM REDUCTION PROGRAM.